ATA Advertising Policy

ATA Board of Directors Policy Statement on
Commercial Advertising in ATA Media Platforms

Approved by the ATA Board of Directors on May 6, 2014

  1. ATA shall accept paid advertisements within Tinnitus Today, the ATA website, and other appropriate media platforms, so long as all advertisements have been approved by the ATA staff, meet the requirements stated in ATA’s advertising contract and do not jeopardize  the ATA mission or status as a tax exempt 501(c)(3) organization.  
  2. ATA may accept advertisements from other non-profit organizations at reduced rates (in consideration) or in return for a reciprocal agreement to publish our advertisements in their publications at no or lowered cost. 
  3. ATA will consider advertisements from non-tinnitus and non-medical companies interested in marketing to ATA’s membership and readership demographics. These potential advertisers will be held to the same rigorous legal and moral standards as “traditional” tinnitus product and service providers. 
  4. ATA will not accept advertising for supplements, over-the-counter drugs, prescription drugs, or other medications, which are marketed to cure tinnitus.
  5. ATA will neither advertise nor promote clinical trials for any product or service, unless the trials are already listed on the U.S. National Institutes of Health’s Clinical Trials database (
  6. The ATA staff shall record and save any complaints, registered with ATA from the public, related to specific advertisers or advertisements displayed on association media properties.  However, the association takes no position on—and shall not mediate—disputes between advertisers and their customers.
  7. The staff under the direction of the Executive Director (ED) will develop a media guide, outlining rates, workflow timelines and artwork standards for all advertisements.

Advertising Disclaimer and Non-Favoritism Policy

ATA's publication of any advertisement in any kind of media does not, in any way or manner, constitute or imply ATA's approval or endorsement of any advertised product or service.  There is currently no known cure for tinnitus.  ATA does not favor or endorse any commercial product or service.